Clinical Trials Logo

Diabetic Foot clinical trials

View clinical trials related to Diabetic Foot.

Filter by:

NCT ID: NCT05417425 Completed - Clinical trials for Diabetic Foot Ulcers

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers

Start date: September 1, 2022
Phase: Phase 1
Study type: Interventional

This study is to evaluate the efficacy of OCMâ„¢ used in combination with off-loading devices for the treatment of diabetic foot ulcers.

NCT ID: NCT05413746 Completed - Diabetes Mellitus Clinical Trials

REOXCARE Dressing to Improve Healing in Diabetic Foot Ulcers (DFU)

REOXDFU
Start date: February 5, 2018
Phase: N/A
Study type: Interventional

It has been shown that diabetic patients present a significant increase in markers related to oxidative stress, which increases even more in those with diabetic foot ulcers and gradually depending on the severity of the injury and inversely to the mechanisms of physiological antioxidants of these patients. Therefore, these patients present a situation of oxidative stress (high lipid peroxidation), with an insufficient level of antioxidant enzymes to reverse this state, which leads to maintenance of the inflammatory situation and therefore the chronification of the ulcer. Investigators' aim in this study is to measure the benefits that the application of the product with antioxidant capacity REOXCARE can bring, together with the usual good clinical wound care guidelines and other essential therapeutic activities, such as pressure relief in the area of the ulcers.

NCT ID: NCT05404295 Completed - Diabetic Foot Clinical Trials

The Effect of Treatment With Umbilical Cord Blood Platelet Lysate on Diabetic Foot Ulcers

Start date: June 10, 2019
Phase: Phase 4
Study type: Interventional

Application of autologous Platelet Rich Plasma (PRP) has been a major breakthrough for the treatment of diabetic foot ulcers, as it provides the necessary growth factors which enhance tissue healing. Human umbilical cord blood platelet lysate (UCB-PL) contains a supraphysiological concentration of growth factors. The aim of the study is to evaluate the efficacy of umbilical cord blood platelet lysate (UCB-PL) gel for the treatment of diabetic foot ulcer.

NCT ID: NCT05404178 Completed - Diabetic Foot Clinical Trials

Turkish Validity-Reliability Study of the Diabetic Foot Self-Care Questionnaire

Start date: June 10, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the translation, cross-cultural adaptation and psychometric properties of the Diabetic Foot Self-Care Questionnaire in patients with primary Type 2 Diabetes.

NCT ID: NCT05395442 Completed - Clinical trials for Type2 Diabetes Mellitus

Web-based Diabetic Foot Care Training Prepared With the Health Belief Model for Type 2 Diabetes Patients

dabe
Start date: June 3, 2022
Phase: N/A
Study type: Interventional

Diabetes Mellitus (DM), insulin secretion, insulin action or this It is a chronic metabolic disease characterized by hyperglycemia caused by a defect in both of these factors. It is an important public health problem that causes organ and function losses due to the complications it creates, negatively affects the life span and quality, and creates a social and economic burden.Diabetic foot, known as an important complication of DM, is an important problem in that it causes deterioration in the quality of life of the patient, frequent and long-term hospitalizations, serious increase in the cost of treatment, lower extremity amputations and increased mortality. As a result of the literature review, it was assumed that the level of knowledge about diabetic foot care could affect diabetic foot care behaviors, self-efficacy and possible diabetic foot complications. In addition to conventional information, a Web-based education based on a health belief model can create awareness in individuals and minimize the risk of diabetic foot ulceration or amputation. The aim of this study is to determine the effect of web-based diabetic foot care training prepared according to SIM on the knowledge levels, self-efficacy and care behaviors of individuals with diabetes.

NCT ID: NCT05353114 Completed - Diabetic Foot Clinical Trials

Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting

Smartfitting
Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Patients with diabetes at high risk of ulceration require a perfect fitting shoe to avoid high shear and pressure forces. Neuropathy skews sensory perceptions and can alter the proper selection of the therapeutic footwear. The aims of study were to evaluate the ability of high-risk patients with diabetes in remission to select the proper therapeutic footwear and to validate a novel 3D foot scanner app for selecting the proper fitting therapeutic footwear.

NCT ID: NCT05338463 Completed - Clinical trials for Chronic Diabetic Foot Ulcer

Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

Start date: December 1, 2021
Phase: Phase 4
Study type: Interventional

Evaluate the Safety and Efficacy of Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in dialysis patients This study aimed to evaluate the effects of a topical cream containing Plectranthus amboinicus and Centella Asiatica when applied topically to diabetic foot ulcers in uremia patients with PAOD.

NCT ID: NCT05324930 Completed - Diabetic Foot Ulcer Clinical Trials

Evaluating the Effectiveness of Piscean Derived Collagen Dressing on Neuropathic Diabetic Foot Ulcer in T2DM Patients

Start date: December 2, 2021
Phase: N/A
Study type: Interventional

Diabetic foot ulcers (DFU) are challenging to treat with complicated healing processes and require advanced wound care. Piscean collagen has the potential to promote the regenerative process while remaining cost-effective and with minimal side effects. In this study, the efficacy of a piscean collagen matrix dressing was compared with a standard dressing of saline-moistened gauze for wound healing in patients with neuropathic DFU. This is a double-blinded, randomised clinical trial.

NCT ID: NCT05243810 Completed - Diabetic Foot Ulcer Clinical Trials

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers

Start date: November 28, 2022
Phase: N/A
Study type: Interventional

The objective of this single-arm feasibility study is to investigate the safety and impact of the topical EPC Silver Wound Gel (EPC-123) in the management of diabetic foot ulcer wounds not progressing under the current standard of care.

NCT ID: NCT05215730 Completed - Diabetic Foot Ulcer Clinical Trials

Comparison of Wound Healing Between MedCu Dressings With Copper Oxide and Negative Pressure Wound Therapy Treatment

Start date: July 7, 2021
Phase: N/A
Study type: Interventional

Randomized multisite two arms study in which one arm of patients will be treated with Negative Pressure Wound Therapy (NPWT) known also as Vacuum-assisted closure (VAC) treatment ("VAC Arm") and the second arm of patients will be treated with MedCu wound dressings with copper oxide (COD) ("Copper Arm"). The study goals are to compare the efficacy, cost and convenience between MedCu Wound Dressings with Copper Oxide (COD) and Negative Pressure Wound Therapy of diabetic foot wounds.